2017
DOI: 10.1016/j.arth.2017.02.019
|View full text |Cite
|
Sign up to set email alerts
|

A Prospective, Randomized Trial Comparing Liposomal Bupivacaine vs Fascia Iliaca Compartment Block for Postoperative Pain Control in Total Hip Arthroplasty

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 36 publications
(17 citation statements)
references
References 14 publications
0
17
0
Order By: Relevance
“…4 Among them is a nonopioid local anesthetic LB, which has recently been shown to reduce the overall pain, hospital length of stay, and opioid consumption in patients having undergone nonspinal orthopaedic procedures, including total hip and knee arthroplasty. 21,22 Similar outcomes have also been documented in nonorthopedic cases, including hemorrhoidectomy, bunionectomy, and colorectal and retropubic slingplacement surgeries. 16,17,23,24 Despite these findings, the local anesthetic's effectiveness in reducing postoperative pain and opioid use in spine surgeries has not been well defined.…”
Section: Discussionmentioning
confidence: 57%
“…4 Among them is a nonopioid local anesthetic LB, which has recently been shown to reduce the overall pain, hospital length of stay, and opioid consumption in patients having undergone nonspinal orthopaedic procedures, including total hip and knee arthroplasty. 21,22 Similar outcomes have also been documented in nonorthopedic cases, including hemorrhoidectomy, bunionectomy, and colorectal and retropubic slingplacement surgeries. 16,17,23,24 Despite these findings, the local anesthetic's effectiveness in reducing postoperative pain and opioid use in spine surgeries has not been well defined.…”
Section: Discussionmentioning
confidence: 57%
“…A slow-release mechanism involving reorganization of the barrier lipid membranes is sustained for up to 92 h with concomitant pain control for up to 72 h, as compared to 7-12 h with standard bupivacaine. Studies show bupivacaine decreased pain compared to placebo, the use of opioids and the hospital costs (Yeung et al 2018;Mazloomdoost et al 2017;Sabesan et al 2017;Declaire et al 2017;Smith et al 2017;Mcgraw-tatum et al 2017;Abildgaard et al 2017;Alijanipour et al 2016;Davidovitch et al 2017). Although the liposomal bupivacaine is not a nanoparticle (3-30 μm mean diameter), it is mentioned here because it is one of the most recent liposomal formulations approved.…”
Section: Pain Management: Bupivacainementioning
confidence: 99%
“…Postoperative pain intensity was calculated using the area under the curve (AUC) for the VAS scores for the first 48 hours of inpatient stay (AUC ¼ P [Pain score  Δtime]). 16…”
Section: Data Collectionmentioning
confidence: 99%